‘Unspecified nature' vs. ‘uncertain behavior': Know when to use each, or risk denials

Why This Topic Matters

Misclassifying neoplasm-related diagnoses can lead to denials, delayed payment, or coding that does not match the documentation. Understanding the article helps coders assess when pathology, physician documentation, and payer policy influence diagnosis selection.

Article Sections

1. Neoplasm terminology and denial risk

   Introduces the coding issue and the payer concerns that can arise when neoplasm terminology is not supported by the record.

2. How physician wording affects diagnosis selection

   Reviews how different descriptive terms in the chart are treated in relation to neoplasm classification.

3. Uncertain behavior and pathology documentation

   Discusses the role of pathology findings and documentation in distinguishing among neoplasm categories.

4. Clinical context and broader coding considerations

   Addresses broader situations where a lesion, enlargement, or other finding may influence diagnosis coding and coverage.

5. PSA testing and coverage notes

   Summarizes the article’s discussion of laboratory coverage context and related diagnosis list changes.